Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: A cost-effectiveness study.

Koleva-Kolarova, RGGreuter, MJWFeenstra, TLVermeulen, KMde Vries, EFJParkin, DBuskens, Ede Bock, GH2025-03-262025-03-2620182973198710.18632/oncotarget.24869https://rivm.openrepository.com/handle/10029/651095Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: A cost-effectiveness study.ArticleOncotarget 2018; 9(28):19836-462025-03-26